Trustmark Corp (TRMK) Tops Q2 EPS by 5c
Get Alerts TRMK Hot Sheet
EPS Growth %: +3.3%
Financial Fact:
Net Interest Income After Provision for Loan Losses: 92.59M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Trustmark Corp (NASDAQ: TRMK) reported Q2 EPS of $0.59, $0.05 better than the analyst estimate of $0.54.
Second Quarter Highlights
- Revenue, excluding interest and fees on acquired loans, increased 2.4% linked quarter to total $147.5 million
- The net interest margin (FTE), excluding acquired loans, was 3.46% in the second quarter, up 9 basis points from the prior quarter
- Sustained strong credit performance reflected in reduced nonperforming assets
- Efficiency ratio improved to 64.90%
Gerard R. Host, President and CEO, stated, “The second quarter showed the value of the diverse Trustmark franchise, with solid loan growth across our five state footprint. We continued to focus on our strategic initiatives of balance sheet optimization, capital deployment through additional share repurchases and disciplined expense management. We also continued to maintain and expand customer relationships in our other lines of businesses, as evidenced by strength in insurance commissions and mortgage loan production volumes. This past quarter – as part of the J.D. Power 2018 U.S. Retail Banking Satisfaction Study – Trustmark was recognized as having the ‘Highest Customer Satisfaction with Retail Banking in the South Central Region’*. We appreciate this recognition from our customers and thank our associates for their commitment to excellent customer service. Thanks to our talented associates, solid profitability and strong capital base, Trustmark remains well positioned to continue meeting the needs of our customers and creating long-term value for our shareholders.”
For earnings history and earnings-related data on Trustmark Corp (TRMK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- C.H. Robinson acquires DeSpir Logistics for $75 million
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
Create E-mail Alert Related Categories
Earnings, Guidance, Management CommentsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share